Incidence of and risk factors for newly diagnosed hyperkalemia after hospital discharge in non-dialysis-dependent CKD patients treated with RAS inhibitors.
Renin-angiotensin system (RAS) inhibitors have been increasingly prescribed due to their beneficial effects on end-organ protection. Iatrogenic hyperkalemia is a well-known life-threatening complication of RAS inhibitor use in chronic kidney disease (CKD) patients. We hypothesized that CKD patients...
Main Authors: | Yuki Saito, Hiroyuki Yamamoto, Hideki Nakajima, Osamu Takahashi, Yasuhiro Komatsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5587314?pdf=render |
Similar Items
-
Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care
by: Silvio Borrelli, et al.
Published: (2021-03-01) -
Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients.
by: Mi-Yeon Yu, et al.
Published: (2017-01-01) -
A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake
by: Kazuhito Fukuoka, et al.
Published: (2017-07-01) -
Hyperkalemia presenting as wide-complex tachycardia in a dialysis patient
by: Gupta Ankur, et al.
Published: (2010-01-01) -
Initial and Recurrent Hyperkalemia Events in Patients With CKD in Older Adults: A Population-Based Cohort Study
by: Sriram Sriperumbuduri, et al.
Published: (2021-05-01)